{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:49:04Z","timestamp":1792586944707,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.semnuclmed.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T02:53:03Z","timestamp":1780195983000},"page":"664-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of cardiac PET imaging in cardiac amyloidosis"],"prefix":"10.1053","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-0484","authenticated-orcid":false,"given":"Mouaz H.","family":"Al-Mallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2026.102727","article-title":"Cardiac amyloidosis: current and pipeline of therapies for the nuclear imager","volume":"59","author":"Davis","year":"2026","journal-title":"J Nuclear Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0002","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10741-022-10226-w","article-title":"Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?","volume":"27","author":"Saad","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0003","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/HCO.0000000000001167","article-title":"Nuclear imaging techniques for cardiac amyloidosis","volume":"39","author":"Saad","year":"2024","journal-title":"Curr Opin Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0004","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12350-019-01761-5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-diagnostic criteria and appropriate utilization","volume":"27","author":"Dorbala","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102231","article-title":"Cardiac positron emission tomography\/computed tomography (PET\/CT) in current cardiology guidelines","volume":"48","author":"Alwan","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0007","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s10741-021-10183-w","article-title":"The utility of positron emission tomography in cardiac amyloidosis","volume":"27","author":"Saeed","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0008","article-title":"Best practices in nuclear imaging for the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) in KSA: the eagle eyes of local experts","volume":"14","author":"Alqarni","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0009","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10741-021-10174-x","article-title":"99m)technetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions","volume":"27","author":"Saad","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102078","article-title":"Current practices in amyloidosis imaging with bone-avid tracer cardiac scintigraphy","volume":"44","author":"Cuddy","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0011","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jcmg.2024.11.003","article-title":"Development of imaging endpoints for clinical trials in AL and ATTR amyloidosis: proceedings of the amyloidosis forum","volume":"18","author":"Dorbala","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2026.1747625","article-title":"Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study","volume":"6","author":"Tingen","year":"2026","journal-title":"Front Nuclear Med"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0013","first-page":"1337","article-title":"Diagnostic accuracy of [11C] PIB positron emission tomography for detection of cardiac amyloidosis","volume":"13","author":"Rosengren","year":"2020","journal-title":"Cardiovascular Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0014","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s12350-019-01961-z","article-title":"Reproducibility and repeatability of assessment of myocardial light chain amyloidosis burden using 18F-florbetapir PET\/CT","volume":"28","author":"Nodoushani","year":"2021","journal-title":"J Nuclear Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0015","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0016","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcmg.2024.05.002","article-title":"Prognostic value of left ventricular (18)F-Florbetapir uptake in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0017","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ehjci\/jeae332","article-title":"Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis","volume":"26","author":"Vergaro","year":"2025","journal-title":"Eur Heart J-Cardiovascular Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0018","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nuclear Med"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","article-title":"Beta-amyloid imaging with florbetaben","volume":"3","author":"Sabri","year":"2015","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0021","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1007\/s00259-020-04861-4","article-title":"18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis","volume":"47","author":"Papathanasiou","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0022","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13506129.2022.2141623","article-title":"The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis","volume":"30","author":"Abrahamson","year":"2023","journal-title":"Amyloid"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0023","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jcmg.2023.09.002","article-title":"Shining a Radiant Light on Cardiac Amyloidosis With Novel (124)I-Evuzamitide PET Imaging","volume":"16","author":"Pelletier-Galarneau","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102451","article-title":"A tale of two tracers - amyloid imaging with investigational radiotracers iodine ((124)I) evuzamitide and (99m)Tc-p5+14 (AT-05)","volume":"56","author":"Martin","year":"2026","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0025","article-title":"An era of precision: Emerging, research, and adjunct radiotracers for nuclear imaging of cardiac amyloidosis","volume":"59s","author":"Wall","year":"2026","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2026.102707","article-title":"Assessment of cardiac involvement in rare forms of amyloidosis using positron emission tomography\/computed tomography with (124)I-evuzamitide ((124)I-p5+14, AT-01)","author":"Clerc","year":"2026","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017807","article-title":"(124)I-Evuzamitide PET\/CT Diagnosis of Wild-Type Transthyretin Amyloid Cardiomyopathy in a Woman With Negative Diagnostic Evaluation","volume":"18","author":"Kurian","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0028","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using (124)I-evuzamitide ((124)I-P5+14) versus (18)F-Florbetapir: A pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0029","first-page":"799","article-title":"Early detection of transthyretin cardiac amyloidosis using 124I-evuzamitide positron emission tomography\/computed tomography","volume":"18","author":"Smiley","year":"2025","journal-title":"Cardiovascular Imag"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0030","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine ((124)I) evuzamitide ((124)I-p5+14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0031","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0735-1097(25)01667-5","article-title":"Diagnostic performance of cardiac and whole-body 124I-evuzamitide (AT-01) PET\/MRI in systemic amyloidosis","volume":"85","author":"Masri","year":"2025","journal-title":"J Am College Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0032","doi-asserted-by":"crossref","DOI":"10.31083\/RCM37731","article-title":"Diagnostic performance of positron emission tomography in the assessment of systemic amyloidosis: a systematic review and meta-analysis","volume":"26","author":"Zhu","year":"2025","journal-title":"Rev Cardiovascular Med"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0033","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jcmg.2024.12.011","article-title":"Cardiac imaging trends: a decade of Medicare data","volume":"18","author":"Sayed","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102472","article-title":"Cardiac nuclear imaging workforce: trends from Medicare part B (2013-2022)","volume":"54","author":"Alwan","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102030","article-title":"Cardiac positron emission tomography and other modalities for coronary artery disease assessment: a snapshot from the Medicare data","volume":"41","author":"Al-Mallah","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2026.102707","article-title":"Office- vs hospital-based cardiac imaging among part B Medicare beneficiaries for evaluating coronary artery disease","volume":"5","author":"Sayed","year":"2026","journal-title":"JACC Adv"},{"key":"10.1053\/j.semnuclmed.2026.05.007_bib0037","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1093\/eurheartj\/ehaf450","article-title":"Artificial intelligence-enabled electrocardiography and echocardiography to track preclinical progression of transthyretin amyloid cardiomyopathy","volume":"46","author":"Oikonomou","year":"2025","journal-title":"Eur Heart J"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:32:30Z","timestamp":1792585950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001299826001182"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.007","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cardiac PET imaging in cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}